On 9 October 2026, QINGLING MOTORS (01122.HK) agreed to acquire 30.43% of Isuzu (China) Engine for about RMB660 million, giving it 50% and joint control.
On 9 October 2026, JUJIANG CONS (01459.HK) applied to the CSRC to convert 400,000,000 Domestic Shares into H Shares, which would leave none in issue.
On 9 October 2026, CARMEN CENTURY (00612.HK) said trading will remain suspended until it fulfils the resumption guidance; the halt began on 30 June 2025.
On 9 Oct 2026, CIRC (01763.HK) said its subsidiary obtained NMPA drug registration for a 50mg 13C-urea breath test kit; launch expected in December 2026.
On 9 Oct 2026, AOM INT'L (00381.HK) delayed to 23 Oct the circular for its share consolidation and loan capitalisation of Hubei convertible bonds.
On 9 Oct 2026, MIKO INTL (01247.HK) said an executive director resigned, citing personal affairs, and a new authorised representative was appointed.
On 9 Oct 2026, YIDU TECH (02158.HK) disclosed a US$65m secured loan product with Goldman Sachs, a discloseable transaction and a Rule 13.13 advance.
On 9 Oct 2026, MINISO (09896.HK) said mainland China Q3 GMV rose 25-30% and its YOYO IP topped RMB1bn in nine-month GMV.
On 9 Oct 2026, STAR SHINE HLDG (01440.HK) proposed a four-for-one share subdivision and to cut the board lot to 500 subdivided shares, effective ~23 Nov 2026.
On 9 October 2026, HK TECH VENTURE (01137.HK) posted September monthly GMV of HKD 764mn (+17.7% YoY) and average daily GMV of HKD 25.5mn (+18.1%).
On 9 October 2026, DATANG POWER (00991.HK) signed a capital increase pact, injecting RMB 627.74mn and Datang Group RMB 941.62mn into Datang Nuclear Power.
On 9 Oct 2026, ZCZL (00564.HK) said controlling shareholder Hongyi Investment pledged 10.01m A shares to CITIC Securities; cumulative 43.87% of its stake.
On 9 Oct 2026, HAIZHI TECH GP (02706.HK) signed a strategic cooperation framework deal with Jointown on pharma distribution digital transformation.
On 9 Oct 2026, HANG YICK HLDGS (01894.HK) said Wei Huaping's voluntary cash partial offer for 30mn shares cleared its pre-condition with Rule 28.1 consent.
On 9 Oct 2026, SUNSHINE OIL (02012.HK) said it has fully repaid the petitioning creditor Zhu Huiwen, except legal costs.
On 9 Oct 2026, BASECARE-B (02170.HK) plans open-market H-share buybacks of up to RMB 5mn under a mandate covering up to 10% of H shares as at 4 June 2026.
